Ionis Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US4622221004

SecurityIONS / Ionis Pharmaceuticals, Inc.
InstitutionParallel Advisors, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Parallel Advisors, LLC ownership in IONS / Ionis Pharmaceuticals, Inc.

On June 2, 2026 - Parallel Advisors, LLC filed a 13F-HR/A form disclosing ownership of 0 shares of Ionis Pharmaceuticals, Inc. (US:IONS) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 1,882 shares of Ionis Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Parallel Advisors, LLC has a history of taking positions in derivatives of the underlying security (IONS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IONS / Ionis Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-06-02 2026-03-31 13F/A-1 IONIS PHARMACEUTICALS INC COM Stock 462222100 0 -1,882 -100.00 0 -100.00
2026-02-11 2025-12-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 1,882 5 0.27 149 21.31 0.0027
2025-11-13 2025-09-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 1,877 5 0.27 123 67.12 0.0022
2025-07-08 2025-06-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 1,872 1,127 151.28 74 231.82 0.0015
2025-04-08 2025-03-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 745 -214 -22.31 22 -33.33 0.0005
2025-02-10 2024-12-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 959 -69 -6.71 34 -19.51 0.0008
2024-11-13 2024-09-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 1,028 396 62.66 41 36.67 0.0010
2024-08-08 2024-06-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 632 60 10.49 30 25.00 0.0008
2024-05-06 2024-03-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 572 7 1.24 25 -14.29 0.0007
2024-02-12 2023-12-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 565 -106 -15.80 29 -6.67 0.0008
2024-05-20 2023-09-30 13F/A-1 IONIS PHARMACEUTICALS INC COM Stock 462222100 671 -40 -5.63 30 3.45 0.0010
2023-11-14 2023-09-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 671 -40 30 0.0010
2024-05-20 2023-06-30 13F/A-1 IONIS PHARMACEUTICALS INC COM Stock 462222100 711 40 5.96 29 26.09 0.0009
2023-08-04 2023-06-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 711 40 29 0.0009
2024-05-20 2023-03-31 13F/A-1 IONIS PHARMACEUTICALS INC COM Stock 462222100 671 0 0.00 24 -8.00 0.0008
2023-04-25 2023-03-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 671 0 24 0.0008
2023-02-06 2022-12-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 671 -51 -7.06 25 -21.87 0.0011
2022-11-10 2022-09-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 722 -2 -0.28 32 18.52 0.0015
2022-08-01 2022-06-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 724 8 1.12 27 3.85 0.0012
2022-04-28 2022-03-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 716 95 15.30 26 36.84 0.0010
2022-01-20 2021-12-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 621 -102 -14.11 19 -20.83 0.0007
2021-11-02 2021-09-30 13F/A-1 IONIS PHARMACEUTICALS INC COM Stock 462222100 723 295 68.93 24 41.18 0.0010
2021-08-06 2021-06-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 428 -2,534 -85.55 17 -87.22 0.0007
2021-04-23 2021-03-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 2,962 485 19.58 133 -5.00 0.0063
2021-02-02 2020-12-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 2,477 1,567 172.20 140 225.58 0.0076
2020-10-27 2020-09-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 910 -2,213 -70.86 43 -76.63 0.0027
2020-07-16 2020-06-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 3,123 2,236 252.09 184 348.78 0.0120
2020-04-27 2020-03-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 887 -1,933 -68.55 41 -75.88 0.0033
2020-01-30 2019-12-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 2,820 2,000 243.90 170 246.94 0.0128
2019-11-01 2019-09-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 820 0 0.00 49 -7.55 0.0042
2019-08-05 2019-06-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 820 -700 -46.05 53 -56.91 0.0052
2019-05-01 2019-03-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 1,520 -550 -26.57 123 10.81 0.0138
2019-02-05 2018-12-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 2,070 -953 -31.52 111 -28.85 0.0155
2018-11-01 2018-09-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 3,023 2,000 195.50 156 271.43 0.0194
2018-07-30 2018-06-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 1,023 -900 -46.80 42 -50.59 0.0060
2018-05-08 2018-03-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 1,923 -2,300 -54.46 85 -59.91 0.0133
2018-02-13 2017-12-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 4,223 900 27.08 212 16.48 0.0347
2017-11-15 2017-09-30 13F/A-1 IONIS PHARMACEUTICALS INC COM Stock 462222100 3,323 1,250 60.30 182 66.97 0.0313
2017-08-07 2017-06-30 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 2,073 800 62.84 109 78.69 0.0206
2017-05-12 2017-03-31 13F/A-1 IONIS PHARMACEUTICALS INC COM Stock 462222100 1,273 500 64.68 61 64.86 0.0121
2017-05-12 2017-03-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 1,273 61
2017-02-14 2016-12-31 13F IONIS PHARMACEUTICALS INC COM Stock 462222100 773 773 37 0.0087
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2022-01-19 2021-12-31 13F IONIS PHARMACEUTICALS INC COM Stock Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-10-22 2021-09-30 13F IONIS PHARMACEUTICALS INC COM Stock Call 428 17 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.